Comments
The stock of Venus Remedies, a small-cap pharma company surged almost 7 per cent with extraordinary volume on Wednesday. This rally has breached the upper boundary of a narrow sideways movement at ₹149 and closed well above its 21- and 50-day moving averages.
Investors with a short-term view can buy the stock at current levels. Following a medium-term downtrend, the stock found support at around ₹130 in early June and changed direction. Since then, the stock has been on a nascent uptrend.
The daily relative strength index has entered the bullish zone from the neutral region and the weekly RSI is moving higher in the neutral region. Moreover, the daily price rate of change indicator which features in the positive area implies buying interest. The stock can proceed with the ongoing uptrend and reach the price target of ₹160.5 and then ₹163.5 in the upcoming sessions. Buy the stock with a stop-loss at ₹150.5.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.